A study aimed to verify the effectiveness of self-monitoring of blood glucose in patients with non-insulin-treated type 2 diabetes was recently conducted to answer this question. The short answer is “Yes,” and the details of the study are reveled below.
A comprehensive literature search was conducted in PubMed and other legitimate scientific web sources.
Eligible randomised controlled trials were included according to prespecified criteria.
A total of 15 randomized controlled trials, comprising 3383 patients with non-insulin-treated Type II Diabetes, met the inclusion criteria.
The self monitoring of blood glucose intervention improved glycated haemoglobin HbA1c , body mass index, and total cholesterol more effectively than the control in overall effect.
Self monitoring blood glucose moderated HbA1c levels better than the control in all subgroup analyses.
Most of the randomized controlled trials had high risk of bias in blinding, while the overall quality of evidence for HbA1c was moderate according to the GRADE criteria.
Publication bias was moderate for BMI.
The conclusion is that self monitoring of blood glucose improved HbA1c levels in the short term (≤6-month follow-up) and long term (≥12-month follow-up) in patients with Type II diabetes who were not using insulin.
Yours in Health!
Dr. Ken Romeo
Dr. Ken Romeo is a Principal and Chief Clinical Data Coordinator for the Healthy Aging Research Foundation (HARF) in Reno, NV.
Though each article contained on this Blog is derived from published Clinical and Research data contained in various national and international databases with links provided,
NO ARTICLE OR CONCLUSION IS MEANT TO DIAGNOSE, TREAT, PREVENT OR CURE DISEASE.
CONSULT YOUR HEALTH PROFESSIONAL BEFORE MAKING ANY CHANGES TO YOUR HEALTH REGIMEN.
Source: BMJ Open. 2016 Sep 2;6(9)